- 全部删除
- 您的购物车当前为空
我们很想知道您的意见反馈,所以我们在每个页面上都梳理出一个反馈按钮。
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 1,992 | 待询 | |
10 mg | ¥ 3,369 | 待询 |
FTISADTSK acetate 相关产品
产品描述 | FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1]. |
密度 | no data available |
Sequence Short | FTISADTSK |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
溶解度信息 | H2O: 50 mg/mL (48.59 mM), Sonication is recommended. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容